These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 38112525)

  • 1. An Engineered Butyrate-Derived Polymer Nanoplatform as a Mucosa-Healing Enhancer Potentiates the Therapeutic Effect of Magnolol in Inflammatory Bowel Disease.
    Fan X; Zhang Z; Gao W; Pan Q; Luo K; He B; Pu Y
    ACS Nano; 2024 Jan; 18(1):229-244. PubMed ID: 38112525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.
    Pedersen G
    Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microbiota metabolite butyrate constrains neutrophil functions and ameliorates mucosal inflammation in inflammatory bowel disease.
    Li G; Lin J; Zhang C; Gao H; Lu H; Gao X; Zhu R; Li Z; Li M; Liu Z
    Gut Microbes; 2021; 13(1):1968257. PubMed ID: 34494943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut Microbial Metabolite Butyrate and Its Therapeutic Role in Inflammatory Bowel Disease: A Literature Review.
    Recharla N; Geesala R; Shi XZ
    Nutrients; 2023 May; 15(10):. PubMed ID: 37242159
    [No Abstract]   [Full Text] [Related]  

  • 5. pH-responsive CuS/DSF/EL/PVP nanoplatform alleviates inflammatory bowel disease in mice via regulating gut immunity and microbiota.
    Yao J; Chen Y; Zhang L; Cheng Y; Chen Z; Zhang Y; Zheng X; Lv Y; Wang S; Li Z; Zhao J
    Acta Biomater; 2024 Apr; 178():265-286. PubMed ID: 38417643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyaluronic acid-functionalized DDAB/PLGA nanoparticles for improved oral delivery of magnolol in the treatment of ulcerative colitis.
    Li W; Lin J; Zhou J; He S; Wang A; Hu Y; Li H; Zou L; Liu Y
    Int J Pharm; 2024 Mar; 653():123878. PubMed ID: 38325622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intestinal Inflammation Modulates the Epithelial Response to Butyrate in Patients With Inflammatory Bowel Disease.
    Ferrer-Picón E; Dotti I; Corraliza AM; Mayorgas A; Esteller M; Perales JC; Ricart E; Masamunt MC; Carrasco A; Tristán E; Esteve M; Salas A
    Inflamm Bowel Dis; 2020 Jan; 26(1):43-55. PubMed ID: 31211831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction of hyaluronic acid-functionalized magnolol nanoparticles for ulcerative colitis treatment.
    Li Y; Chen T; Chen L; Wu D; Hu J
    Int J Biol Macromol; 2024 May; 268(Pt 2):131920. PubMed ID: 38679261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ROS Scavenging and inflammation-directed polydopamine nanoparticles regulate gut immunity and flora therapy in inflammatory bowel disease.
    Bao M; Wang K; Li J; Li Y; Zhu H; Lu M; Zhang Y; Fan Q; Han L; Wang K; Wang D; Gao Y; Peng B; Ming Z; Liu W
    Acta Biomater; 2023 Apr; 161():250-264. PubMed ID: 36863680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A tailored series of engineered yeasts for the cell-dependent treatment of inflammatory bowel disease by rational butyrate supplementation.
    Wu J; Huang H; Wang L; Gao M; Meng S; Zou S; Feng Y; Feng Z; Zhu Z; Cao X; Li B; Kang G
    Gut Microbes; 2024; 16(1):2316575. PubMed ID: 38381494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microbiota-derived butyrate dynamically regulates intestinal homeostasis through regulation of actin-associated protein synaptopodin.
    Wang RX; Lee JS; Campbell EL; Colgan SP
    Proc Natl Acad Sci U S A; 2020 May; 117(21):11648-11657. PubMed ID: 32398370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of Epithelial Signal Transducer and Activator of Transcription 1 by Interleukin 28 Controls Mucosal Healing in Mice With Colitis and Is Increased in Mucosa of Patients With Inflammatory Bowel Disease.
    Chiriac MT; Buchen B; Wandersee A; Hundorfean G; Günther C; Bourjau Y; Doyle SE; Frey B; Ekici AB; Büttner C; Weigmann B; Atreya R; Wirtz S; Becker C; Siebler J; Neurath MF
    Gastroenterology; 2017 Jul; 153(1):123-138.e8. PubMed ID: 28342759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SCFAs induce autophagy in intestinal epithelial cells and relieve colitis by stabilizing HIF-1α.
    Zhou C; Li L; Li T; Sun L; Yin J; Guan H; Wang L; Zhu H; Xu P; Fan X; Sheng B; Xiao W; Qiu Y; Yang H
    J Mol Med (Berl); 2020 Aug; 98(8):1189-1202. PubMed ID: 32696223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mucosal metabolism in ulcerative colitis and Crohn's disease.
    Duffy MM; Regan MC; Ravichandran P; O'Keane C; Harrington MG; Fitzpatrick JM; O'Connell PR
    Dis Colon Rectum; 1998 Nov; 41(11):1399-405. PubMed ID: 9823806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Butyrate utilization by the colonic mucosa in inflammatory bowel diseases: a transport deficiency.
    Thibault R; Blachier F; Darcy-Vrillon B; de Coppet P; Bourreille A; Segain JP
    Inflamm Bowel Dis; 2010 Apr; 16(4):684-95. PubMed ID: 19774643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chitosan oligosaccharide as potential therapy of inflammatory bowel disease: therapeutic efficacy and possible mechanisms of action.
    Yousef M; Pichyangkura R; Soodvilai S; Chatsudthipong V; Muanprasat C
    Pharmacol Res; 2012 Jul; 66(1):66-79. PubMed ID: 22475725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ketogenic diet aggravates colitis, impairs intestinal barrier and alters gut microbiota and metabolism in DSS-induced mice.
    Li S; Zhuge A; Wang K; Lv L; Bian X; Yang L; Xia J; Jiang X; Wu W; Wang S; Wang Q; Li L
    Food Funct; 2021 Oct; 12(20):10210-10225. PubMed ID: 34542110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving silymarin oral bioavailability using silica-installed redox nanoparticle to suppress inflammatory bowel disease.
    Nguyen TT; Trinh NT; Tran HN; Tran HT; Le PQ; Ngo DN; Tran-Van H; Van Vo T; Vong LB; Nagasaki Y
    J Control Release; 2021 Mar; 331():515-524. PubMed ID: 33616078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Orally Administrated Inflamed Colon-Targeted Nanotherapeutics for Inflammatory Bowel Disease Treatment by Oxidative Stress Level Modulation in Colitis.
    Min DK; Kim YE; Kim MK; Choi SW; Park N; Kim J
    ACS Nano; 2023 Dec; 17(23):24404-24416. PubMed ID: 38039189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterogeneous expression of human cathelicidin hCAP18/LL-37 in inflammatory bowel diseases.
    Schauber J; Rieger D; Weiler F; Wehkamp J; Eck M; Fellermann K; Scheppach W; Gallo RL; Stange EF
    Eur J Gastroenterol Hepatol; 2006 Jun; 18(6):615-21. PubMed ID: 16702850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.